In this regard, it was recently shown that a mutation in NOTCH3 causes cerebral autosomal‐dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and NOTCH3 selective agonists were suggested to be potentially effective in treating the disease.33 The gene discussed is NOTCH3; the disease is Leukoencephalopathy.